Global Health Data Exchange - Discover the World's Health Data

Update on Meningococcal A Vaccine Development and Introduction

Nav

General Info
Geography 
Benin (BEN)
Burundi (BDI)
Chad (TCD)
Bas-Congo
Eritrea (ERI)
Ethiopia (ETH)
Ghana (GHA)
Guinea (GIN)
Kenya (KEN)
Mali (MLI)
Niger (NER)
Nigeria (NGA)
Rwanda (RWA)
Senegal (SEN)
Sudan (SDN)
Tanzania (TZA)
Uganda (UGA)
Coverage type 
Country
Time period covered 
01/2010 - 12/2016
Data type
Summary 

This presentation, delivered at the WHO Product Development for Vaccines Advisory Committee (PD-VAC) meeting, 7-9 September 2015, provides an update from the Meningitis Vaccine Project (MVP), a collaboration between the WHO and PATH dedicated to eliminating epidemic meningitis in sub-Saharan Africa. It covers the introduction and rollout in 26 countries of MenAfriVac, a vaccine developed by the project to protect infants of less than a year to people up to 29 years of age in the African meningitis belt against meningococcal bacterium Neisseria meningitidis group A.

Citation
Authors 
Preziosi MP
Suggested citation 

Preziosi MP, Department of Immunization, Vaccines, and Biologicals (World Health Organization). Update on Meningococcal A Vaccine Development and Introduction. Presented at: WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC); 2015 Sep 7-9; Geneva, Switzerland.